Background: Type 2 diabetes mellitus, beyond its well-known cardiovascular and neurological complications, is now increasingly recognized as having deleterious effects on bone tissue. It’s thus presented as an independent risk factor for bone fragility with a considerable fracture risk relating to many more or less intricate parameters. The general objective of our study is to assess bone mass during type 2 diabetes in Senegalese women. Methodology: We had carried out a cross-sectional and descriptive study. Socio-demographic characteristics were collected on the basis of a questionnaire. Then each of the subjects had undergone a complete clinical examination followed by a blood sample for a biological assessment of certain cardiovascular risk factors. Bone mass was measured using a bio-impedancemeter. Results: We recruited 88 women with type 2 diabetes and 83 healthy control women. The mean age of diabetic subjects was 52.7 years ± 6.8 (with extremes of 39 and 74 years). In control, the mean age was 51.0 ± 8.5 years (with extremes of 35 and 72 years). Among the diabetic subjects, 22 subjects or 25% practiced a regular walk against 27 (32.5%) in the control. Forty-three among the diabetic subjects (48.8%) were known hypertensive and followed. According to the body mass index, 71 patients (80.7%) were overweight compared to 59 (71.1%) controls. According to the waist size, 80 (90.9%) diabetic subjects had an elevated waist size compared to 69 control women (83.1%). Among diabetic subjects, 41 patients (46.5%) were hyperglycemic imbalance according to fasting blood glucose and 59 patients (67%) according to glycated hemoglobin level. Thirty-seven diabetics (42%), had both high fasting blood glucose and elevated glycated hemoglobin. The mean duration of diabetes was 8.68 ± 7.18 years. We found significantly higher bone mass in type 2 diabetic subjects (p = 0.03). Among diabetics, 27.3% had low bone mass compared to 36.1% of control. It’s noted that the subjects of the “low bone mass” group among the control subjects also have a significant drop in other anthropometric parameters (weight, body mass index, waist size, muscle mass). It should also be noted that the fat mass is significantly higher in diabetic subjects with normal or even high bone mass. In control subjects, bone mass was positively correlated with weight (r = 0.36; p = 0.001), muscle mass (r = 0.93; p < 0.0001) and fasting blood glucose (r = 0.26; p = 0.02); and negatively correlate with age (r = 0.22; p = 0.04). On the other hand, in type
References
[1]
Janghorbani, M., Van Dam, R.M., Willett, W.C. and Hu, F.B. (2007) Systematic Review of Type 1 and Type 2 Diabetes Mellitus and Risk of Fracture. American Journal of Epidemiology, 166, 495-505. https://doi.org/10.1093/aje/kwm106
[2]
Vestergaard, P., Rejnmark, L. and Mosekilde, L. (2005) Relative Fracture Risk in Patients with Diabetes Mellitus, and the Impact of Insulin and Oral Antidiabetic Medication on Relative Fracture Risk. Diabetologia, 48, 1292-1299. https://doi.org/10.1007/s00125-005-1786-3
[3]
Bonds, D.E., Larson, J.C., Schwartz, A.V., Strotmeyer, E.S., Robbins, J., Rodriguez, B.L., et al. (2006) Risk of Fracture in Women with Type 2 Diabetes: The Women’s Health Initiative Observational Study. Journal of Clinical Endocrinology & Metabolism, 91, 3404-3410. https://doi.org/10.1210/jc.2006-0614
[4]
Fabre, S. and Cohen, M. (2018) Os du diabétique: Un risque de fracture plus élevé. Diabète & Obésité, 13, 86-90.
[5]
Evans, J.M., Newton, R.W., Ruta, D.A., MacDonald, T.M. and Morris, J.-C. (2000) Socio-Economic Status, Obesity and Prevalence of Type 1 and Type 2 Diabetes Mellitus. Diabetic Medicine, 17, 478-480. https://doi.org/10.1046/j.1464-5491.2000.00309.x
[6]
Bruno, G., Runzo, C., Cavallo-Perin, P., Merletti, F., Rivetti, M., Pinach, S., et al. (2005) Incidence of Type 1 and Type 2 Diabetes in Adults Aged 30 - 49 Years: The Population-Based Registry in the Province of Turin, Italy. Diabetes Care, 28, 2613-2619. https://doi.org/10.2337/diacare.28.11.2613
[7]
Holman, N., Young, B. and Gadsby, R. (2015) Current Prevalence of Type 1 and Type 2 Diabetes in Adults and Children in the UK. Diabetic Medicine, 32, 1119-1120. https://doi.org/10.1111/dme.12791
[8]
Schwartz, A.V. (2016) Epidemiology of Fractures in Type 2 Diabetes. Bone, 82, 2-8. https://doi.org/10.1016/j.bone.2015.05.032
[9]
Hofbauer, L.C., Brueck, C.C., Singh, S.K. and Dobnig, H. (2007) Osteoporosis in Patients with Diabetes Mellitus. Journal of Bone and Mineral Research, 22, 1317-1328. https://doi.org/10.1359/jbmr.070510
[10]
Forsen, L., Meyer, H.E., Midthjell, K. and Edna, T.H. (1999) Diabetes Mellitus and the Incidence of Hip Fracture: Results from the Nord-Trondelag Health Survey. Diabetologia, 42, 920-925. https://doi.org/10.1007/s001250051248
[11]
Schwartz, A.V., Sellmeyer, D.E., Ensrud, K.E., Cauley, J.A., Thabor, H.K., Schreiner, P.J., et al. (2001) Older Women with Diabetes Have an Increased Risk of Fracture: A Prospective Study. Journal of Clinical Endocrinology & Metabolism, 86, 32-38. https://doi.org/10.1210/jcem.86.1.7139
[12]
Räkel, A., Sheehy, O., Rahme, E. and Lelorier, J. (2008) Osteoporosis among Patients with Type 1 and Type 2 Diabetes. Diabetes & Metabolism, 34, 193-205. https://doi.org/10.1016/j.diabet.2007.10.008
[13]
Dhaliwal, R., Cibula, D., Ghosh, C., Weinstock, R.S. and Moïse, A.M. (2014) Bone Quality Assessment in Type 2 Diabetes Mellitus. Osteoporosis International, 25, 1969-1973. https://doi.org/10.1007/s00198-014-2704-7
[14]
Kim, J.H., Choi, H.J., Ku, E.J., Kim, K.M., Kim, S.W., Cho N.H., et al. (2015) Trabecular Bone Score as an Indicator for Skeletal Deterioration in Diabetes. Journal of Clinical Endocrinology & Metabolism, 100, 475-482. https://doi.org/10.1210/jc.2014-2047
[15]
Cortet, B., Lucas, S., Legroux-Gérot, I., Penel, G., Chauveau, C. and Paccou, J. (2019) Conséquences osseuses du diabète et de ses traitements. Revue du Rhumatisme, 86, 155-161. https://doi.org/10.1016/j.rhum.2018.06.004
[16]
Lespessailles, E. (2017) Obesity and Osteoporosis. La Lettre du Rhumatologue, No. 429-430, 22-26.
[17]
Johansson, H., Kanis, J.A., Odén, A., McCloskey, E., Chapurlat, R.D., Christiansen, C., et al. (2014) A Meta-Analysis of the Association of Fracture Risk and Body Mass Index in Women. Journal of Bone and Mineral Research, 29, 223-233. https://doi.org/10.1002/jbmr.2017
[18]
Cao, J.J. (2011) Effects of Obesity on Bone Metabolism. Journal of Orthopaedic Surgery and Research, 6, Article No. 30. https://doi.org/10.1186/1749-799X-6-30
[19]
Hsu, Y.H., Venners, S.A., Terwedow, H.A., Feng, Y., Niu, T., Li, Z., et al. (2006) Relation of Body Composition, Fat Mass, and Serum Lipids to Osteoporotic Fratures and Mineral Bone Density in Chinese Men and Women. American Journal of Clinical Nutrition, 83, 146-154. https://doi.org/10.1093/ajcn/83.1.146
[20]
Kim, C.J., Oh, K.W., Rhee, E.J., Kim, K.H., Jo, S.K., Jung, C.H., et al. (2009) Relationship between Body Composition and Mineral Bone Density (BMD) in Perimenopausal Korean Women. Clinical Endocrinology, 71, 18-26. https://doi.org/10.1111/j.1365-2265.2008.03452.x
[21]
Hamrick, M.W. and Ferrari, S.L. (2008) Leptin and the Sympathetic Connection of Fat to Bone. Osteoporosis International, 19, 905-912. https://doi.org/10.1007/s00198-007-0487-9
[22]
Napoli, N., Pedone, C., Pozzilli, P., Lauretani, F., Ferrucci, L., Incalzi, R.A., et al. (2010) Adiponectin and Bone Mass Density: The InCHIANTI Study. Bone, 47, 1001-1005. https://doi.org/10.1016/j.bone.2010.08.010
[23]
Wongdee, K. and Charoenphandhu, N. (2011) Osteoporosis in Diabetes Mellitus: Possible Cellular and Molecular Mechanisms. World Journal of Diabetes, 2, 41-48. https://doi.org/10.4239/wjd.v2.i3.41
[24]
Krings, U., Rahman, S., Huang, S., Lu, Y., Czernik, P.J. and Lecka-Czernik, B. (2012) Bone Marrow Fat Has Brown Adipose Tissue Characteristics, Which Are Attenuated with Aging and Diabetes. Bone, 50, 546-552. https://doi.org/10.1016/j.bone.2011.06.016
[25]
Volpato, S., Bianchi, L., Lauretani, F., Lauretani, F., Bandinelli, S., Guralnik, J.M., et al. (2012) Role of Muscle Mass and Muscle Quality in the Association between Diabetes and Gait Speed. Diabetes Care, 35, 1672-1679. https://doi.org/10.2337/dc11-2202
[26]
Compston, J. (2018) Type 2 Diabetes Mellitus and Bone. Journal of Internal Medicine, 283, 140-153. https://doi.org/10.1111/joim.12725
[27]
Nicodemus, K.K. and Folsom, A.R. (2001) Iowa Women’s Health Study. Type 1 and Type 2 Diabetes and Incident Hip Fractures in Post-Menopausal Women. Diabetes Care, 24, 1192-1197. https://doi.org/10.2337/diacare.24.7.1192
[28]
Majumdar, S.R., Leslie, W.D., Lix, L.M., Morin, S.N., Johansson, H., Oden, A., et al. (2016) Longer Duration of Diabetes Strongly Impacts Fracture Risk Assessment: The Manitoba BMD Cohort. Journal of Clinical Endocrinology & Metabolism, 101, 4489-4496. https://doi.org/10.1210/jc.2016-2569
[29]
Napoli, N., Chandran, M., Pierroz, D.D., Abrahamsen, B., Schwartz, A.V. and Ferrari, S.L. (2017) Mechanisms of Diabetes Mellitus-Induced Bone Fragility. Nature Reviews Endocrinology, 13, 208-219. https://doi.org/10.1038/nrendo.2016.153
[30]
Makita, Z., Radoff, S., Rayfield, E.J., Yang, Z., Skolnik, E., Delaney, V., et al. (1991) Advanced Glycosylation End Products in Patients with Diabetic Nephropathy. New England Journal of Medicine, 325, 836-842. https://doi.org/10.1056/NEJM199109193251202
[31]
Brownlee, M., Cerami, A. and Vlassara, H. (1988) Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications. New England Journal of Medicine, 318, 1315-1321. https://doi.org/10.1056/NEJM198805193182007
[32]
Aronson, D. and Rayfield, E.J. (2002) How Hyperglycemia Promotes Atherosclerosis: Molecular Mechanisms. Cardiovascular Diabetology, 1, Article No. 1. https://doi.org/10.1186/1475-2840-1-1
[33]
Shanbhogue, V.V., Hansen, S., Frost, M., Brixen, K. and Hermann, A.P. (2017) Bone Disease in Diabetes: Another Manifestation of Microvascular Disease? The Lancet Diabetes & Endocrinology, 5, 827-38. https://doi.org/10.1016/S2213-8587(17)30134-1
[34]
Burghardt, A.J., Issever, A.S., Schwartz, A.V., Davis, K.A., Masharani, U., Majumdar, S., et al. (2010) High-Resolution Peripheral Quantitative Computed Tomographic Imaging of Cortical and Trabecular Bone Microarchitecture in Patients with Type 2 Diabetes Mellitus. Journal of Clinical Endocrinology & Metabolism, 95, 5045-5055. https://doi.org/10.1210/jc.2010-0226
[35]
Patsch, J.M., Burghardt, A.J., Yap, S.P., Baum, T., Schwartz, A.V. and Joseph, G.B. (2013) Increased Cortical Porosity in Type 2 Diabetic Postmenopausal Women with Fragility Fractures. Increased Cortical Porosity in Type 2 Diabetic Postmenopausal Women with Fragility Fractures. Journal of Bone and Mineral Research, 28, 313-324. https://doi.org/10.1002/jbmr.1763
[36]
Petit, M.U., Paudel, M.L., Taylor, B.C., Hughes, J.M., Strotmeyer, E.S., Schwartz, A.V., et al. (2010) Bone Mass and Strength in Older Men with Type 2 Diabetes: The Osteoporotic Fractures in Men Study. Journal of Bone and Mineral Research, 25, 285-291. https://doi.org/10.1359/jbmr.090725
[37]
Farr, J.N., Drake, M.T., Amin, S., Melton, L.J., McCready, L.K., Khosla, S., et al. (2014) In Vivo Assessment of Bone Quality in Postmenopausal Women with Type 2 Diabetes. Journal of Bone and Mineral Research, 29, 787-795. https://doi.org/10.1002/jbmr.2106
[38]
Nilsson, A.G., Sundh, D., Johansson, L., Nilsson, M., Mellström, D., Rudang, R., et al. (2017) Type 2 Diabetes Mellitus Is Associated with Better Bone Microarchitecture but Lower Bone Material Strength and Poorer Physical Function in Elderly Women: A Population-Based Study. Journal of Bone and Mineral Research, 32, 1062-1071. https://doi.org/10.1002/jbmr.3057
[39]
Sundh, D., Rudäng, R., Zoulakis, M., Nilsson, A.G., Darelid, A. and Lorentzon, M. (2016) A High amount of Adipose Tissue Is Associated with High Cortical Porosity and Low Bone Material Strength in Older Women. Journal of Bone and Mineral Research, 31, 749-757. https://doi.org/10.1002/jbmr.2747
[40]
Moyer-Mileur, L.J., Dixon, S.B., Quick, J.L., Askew, E.W. and Murray, M.A. (2004) Bone Mineral Acquisition in Adolescents with Type 1 Diabetes. The Journal of Pediatrics, 145, 662-669. https://doi.org/10.1016/j.jpeds.2004.06.070
[41]
Baumgartner, R.N., Chumlea, W.C. and Roche, A.F. (1988) Bioelectric Impedance Phase Angle and Body Composition. American Journal of Clinical Nutrition, 48, 16-23. https://doi.org/10.1093/ajcn/48.1.16